Nanotechnology treatment reprograms immune cells to reverse autoimmune disease
Parvus Therapeutics today announced the publication in Nature of a seminal paper describing the discovery and applications of a novel therapeutic approach employing nanomedicines, referred to as "Navacims", to reprogram white ...
Feb 17, 2016
0
127